Rouan Sarah Kathryn
CIK: 0001761366
Director
Primary company: Viking Therapeutics, Inc. (VKTX)
Rouan Sarah Kathryn is a corporate insider at Viking Therapeutics, Inc. (VKTX) filing SEC Form 4 transactions. 28 transactions across 2 companies, totaling $64,790 in purchases and $2,282,540 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Purchase | 1,240 | $24.15 | $30K | 1,240 | 3/31/2025 Filed: 4/8/2025 | Filing → | |
| Purchase | 1,240 | $24.15 | $30K | 1,240 | 3/31/2025 Filed: 4/2/2025 | Filing → | |
| Award | 18,800 | $41.12 | $773K | 18,800 | 1/2/2025 Filed: 1/6/2025 | Filing → | |
| Exercise | 11,000 | - | - | 11,000 | 10/25/2024 Filed: 10/25/2024 | Filing → | |
| Sale | 11,000 | $80.89 | $890K | 0 | 10/25/2024 Filed: 10/25/2024 | Filing → | |
| Exercise | 11,000 | $4.88 | $54K | 11,000 | 10/25/2024 Filed: 10/25/2024 | Filing → | |
| Exercise | 25,000 | - | - | 0 | 2/8/2024 Filed: 2/8/2024 | Filing → | |
| Sale | 25,000 | $28.05 | $701K | 0 | 2/8/2024 Filed: 2/8/2024 | Filing → | |
| Exercise | 25,000 | $8.32 | $208K | 25,000 | 2/8/2024 Filed: 2/8/2024 | Filing → | |
| Exercise | 30,000 | - | - | 25,000 | 1/19/2024 Filed: 1/19/2024 | Filing → | |
| Sale | 30,000 | $23.05 | $692K | 0 | 1/19/2024 Filed: 1/19/2024 | Filing → | |
| Exercise | 30,000 | $8.32 | $250K | 30,000 | 1/19/2024 Filed: 1/19/2024 | Filing → | |
| Award | 32,000 | - | - | 32,000 | 1/2/2024 Filed: 1/4/2024 | Filing → | |
| Award | 22,000 | $0.00 | $0 | 22,000 | 1/3/2023 Filed: 1/4/2023 | Filing → | |
| Award | 22,000 | $0.00 | $0 | 22,000 | 1/3/2022 Filed: 1/5/2022 | Filing → | |
NAVIDEA BIOPHARMACEUTICALS, INC. NAVB | Award | 4,892 | $0.00 | $0 | 18,242 | 6/30/2021 Filed: 7/7/2021 | Filing → |
NAVIDEA BIOPHARMACEUTICALS, INC. NAVB | Award | 2,500 | $0.00 | $3 | 2,500 | 1/13/2021 Filed: 1/14/2021 | Filing → |
NAVIDEA BIOPHARMACEUTICALS, INC. NAVB | Award | 2,500 | $0.00 | $3 | 13,350 | 1/13/2021 Filed: 1/14/2021 | Filing → |
| Award | 22,000 | $0.00 | $0 | 22,000 | 1/4/2021 Filed: 1/6/2021 | Filing → | |
NAVIDEA BIOPHARMACEUTICALS, INC. NAVB | Award | 2,500 | $0.00 | $3 | 7,500 | 2/6/2020 Filed: 2/7/2020 | Filing → |
Type
Purchase
Shares
1,240
Price
$24.15
Value
$30K
Type
Purchase
Shares
1,240
Price
$24.15
Value
$30K
Type
Award
Shares
18,800
Price
$41.12
Value
$773K
Type
Exercise
Shares
11,000
Price
-
Value
-
Type
Sale
Shares
11,000
Price
$80.89
Value
$890K
Type
Exercise
Shares
11,000
Price
$4.88
Value
$54K
Type
Exercise
Shares
25,000
Price
-
Value
-
Type
Sale
Shares
25,000
Price
$28.05
Value
$701K
Type
Exercise
Shares
25,000
Price
$8.32
Value
$208K
Type
Exercise
Shares
30,000
Price
-
Value
-
Type
Sale
Shares
30,000
Price
$23.05
Value
$692K
Type
Exercise
Shares
30,000
Price
$8.32
Value
$250K
Type
Award
Shares
32,000
Price
-
Value
-
Type
Award
Shares
22,000
Price
$0.00
Value
$0
Type
Award
Shares
22,000
Price
$0.00
Value
$0
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
Type
Award
Shares
4,892
Price
$0.00
Value
$0
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
Type
Award
Shares
2,500
Price
$0.00
Value
$3
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
Type
Award
Shares
2,500
Price
$0.00
Value
$3
Type
Award
Shares
22,000
Price
$0.00
Value
$0
NAVIDEA BIOPHARMACEUTICALS, INC.
NAVB
Type
Award
Shares
2,500
Price
$0.00
Value
$3
AI Agent
Try asking...